Home Insight

INSIGHT

October 24, 2025

From "made in China" to "defined by China": can NewCo lead the way | Part 1

After learning about the background of NewCo's emergence and classic cases in the previous episode, today we will focus on three key questions: What value does NewCo bring to global innovative pharmaceutical companies? What challenges and limitations does it have? And how should we utilize this model?

October 23, 2025

Shared responsibility in global health: a conversation with Prof. Dr. Axel R. Pries, President of the World Health Summit

October 23, 2025

Partners, not sellers: how Innovent's Co-Co deal is reshaping China's role in global pharma

October 22, 2025

Innovent inks $11.4 Billion cancer drug deal with Takeda, sets new China biotech benchmark

October 22, 2025

China's innovative drug out-licensing deals surpass US $100B milestone in 2025

October 22, 2025

From "Cheap China" to "Innovation Dawn": how global investors bet on Chinese biotech

October 21, 2025

From imports to innovation: mega-financing fuels the race for China's next-gen phaco-vitrectomy systems

October 18, 2025

China's biopharma goes global: innovative drug NewCo partnership case

October 17, 2025

A global call to action: The 7th Nordic Conference on Sustainable Healthcare kicks off in November 2025, co-creating a new blueprint for sustainable healthcare

October 17, 2025

$1B deal follows hot IPO: Leads Biolabs and Dianthus partner on bispecific LBL-047

October 16, 2025

Where does China stand in the global shift to organ-on-a-chip amid FDA push?

October 15, 2025

Kailera Therapeutics secures $600M Series B, advancing Hengrui-licensed obesity drug to global trials

October 15, 2025

From spinoff to listing: how a HKD 4.9B pharma incubated a HKD 6B biotech

October 14, 2025

After GLP-1, what's the next blockbuster in weight loss?

October 13, 2025

Biokin Pharmaceutical's Iza-bren triggers $1.05B BMS milestone, redefining China's biotech playbook

October 13, 2025

Chinese biopharma PegBio taps into high-potential Middle East and Africa markets via exclusive GLP-1 partnership

October 13, 2025

Pfizer leads the way: how U.S. MFN policy will reshape the global drug pricing strategies

October 11, 2025

China's biopharma goes global: the NewCo model explained

October 11, 2025

With JD-backed POMDOCTOR's Nasdaq debut, internet healthcare is back in favor

October 10, 2025

From Suzhou to the world: UgeneX pacts with AviadoBio, licensing gene therapy asset in deal worth up to $413 million

October 08, 2025

The new ADC competitive era: three players, one pipeline, a winning strategy